MedTrace Logo

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease

NCT04100889 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2025-06-05

No results posted yet for this study

Summary

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding Alzheimer's disease.

Conditions

  • Alzheimer Disease
  • Alzheimer Disease 1
  • Alzheimer Disease 2
  • Alzheimer Disease 3
  • Alzheimer Disease 4
  • Alzheimer Disease 5
  • Alzheimer Disease 6
  • Alzheimer Disease 7
  • Alzheimer Disease 8
  • Alzheimer Disease 9, Late-Onset
  • Alzheimer Disease 10
  • Alzheimer Disease 11
  • Alzheimer Disease 12
  • Alzheimer Disease 13
  • Alzheimer Disease 14
  • Alzheimer Disease 15
  • Alzheimer Disease 16
  • Alzheimer Disease 17
  • Alzheimer Disease 18
  • Alzheimer Disease 19
  • Alzheimer Disease, Early Onset
  • Alzheimer Disease, Late Onset
  • Alzheimer Disease Focal

Interventions

OTHER

No Intervention

There is no intervention for this study.

Sponsors & Collaborators

  • ProgenaBiome

    lead OTHER

Principal Investigators

  • Sabine Hazan, MD · ProgenaBiome

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-02
Primary Completion
2030-03-31
Completion
2030-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04100889 on ClinicalTrials.gov